AlloSure: Understanding the test, process, and results.
What is AlloSure?
AlloSure is a blood test. AlloSure results help your transplant team assess the health of your transplanted kidney and aids in the management of your post-transplant care.
How does AlloSure work?
AlloSure measures the level of donor-derived cell-free DNA (dd-cfDNA) in your blood. When injury to the transplanted kidney occurs, dd-cfDNA is released into your blood. An increase in dd-cfDNA can be a sign of rejection. AlloSure provides information that can help your doctor determine the right treatment for you.
What are the benefits of AlloSure?
- Post-transplant surveillance with AlloSure allows doctors to assess the probability of kidney transplant rejection both, accurately and non-invasively
- AlloSure provides information to your doctor that helps in evaluating the health of your transplanted kidney
- AlloSure helps your doctor choose additional tests they may want to order
What is the testing process for AlloSure?
- AlloSure requires a simple blood draw
- The blood sample is sent to the CareDx laboratory for testing
- Your doctor receives your AlloSure result within 3 days of blood draw
What do my results mean?
AlloSure provides the percentage of dd-cfDNA in your blood, which will help your doctor evaluate the health of your transplanted kidney. When combined with standard clinical care and management, AlloSure provides your doctor with information to manage your transplanted kidney.
Talk to your doctor about making AlloSure testing part of your transplant care. If AlloSure is right for you, your doctor will:
- Direct you to a blood draw laboratory
- Have the laboratory collect and send your blood sample in for testing
- Receive your AlloSure test results and determine how to best manage your care